Η XM δεν παρέχει υπηρεσίες σε κατοίκους των Ηνωμένων Πολιτειών Αμερικής.
G
G

Givaudan


Ειδήσεις

Swiss stocks - Factors to watch on June 11

Swiss stocks - Factors to watch on June 11 ZURICH/GDANSK, June 11(Reuters) - Here are some of the main factors that may affect Swiss stocks on Tuesday: SNB SNBN.S The race to appoint the new Swiss central bank chief is nearing an end. The Swiss National Bank's supervisory board is in the final stages of deciding its candidate to replace outgoing Chairman Thomas Jordan, people familiar with the matter have told Reuters.
G
H
S
S

Dsm-firmenich sees boost as weight-loss drugs spur healthier choices

UPDATE 1-Dsm-firmenich sees boost as weight-loss drugs spur healthier choices Weight-loss drugs seen boosting demand for dietary supplements Preventive healthcare could raise interest in new ingredients Updates paragraph 12 to make it clear company is reviewing options including sale or IPO for Animal Nutrition division By Dimitri Rhodes and Matteo Allievi June 10 (Reuters) - The soaring popularity of weight-loss drugs are likely to spur demand for dietary supplements and healthier food formulat
G
K
L
S

Dsm-firmenich sees boost as weight-loss drugs spur healthier choices

Dsm-firmenich sees boost as weight-loss drugs spur healthier choices Weight-loss drugs seen boosting demand for dietary supplements Preventive healthcare could raise interest in new ingredients By Dimitri Rhodes and Matteo Allievi June 10 (Reuters) - The soaring popularity of weight-loss drugs are likely to spur demand for dietary supplements and healthier food formulations, creating growth opportunities for dsm-firmenich, the CEO of the flavours to nutrition company told Reuters.
G
K
L
S

Barclays ups Givaudan to 'equal weight' on better outlook

BUZZ-Barclays ups Givaudan to 'equal weight' on better outlook ** Barclays raises Swiss fragrance maker Givaudan GIVN.S to "equal weight" from "underweight" and hikes its PT by 14% to 4,000 Swiss francs ($4,462), pointing to a better than feared outlook for Fine Fragrances unit ** It says Givaudan's premium valuation reflects strong underlying momentum and expects an 2024 and 2025 adj.
G

Aviva, DCC, Puig Brands

EUROPE RESEARCH ROUNDUP-Aviva, DCC, Puig Brands June 10 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Aviva, DCC and Puig Brands on Monday. HIGHLIGHTS * Aviva AV.L : JP Morgan removes stock from its analyst focus list * Bellway Plc BWY.L : Citigroup raises target price to 3151p from 3033p * Computacenter Plc CCC.L : Peel Hunt raises to buy from add * DCC DCC.L : Jefferies raises target price to 7600p from 7400p * Puig Brands SA P
A
A
A
A
B
C
C
D
D
D
G
H
N
P
R
U
V
A
A
B
L
Z

Argenx, Hermes, National Grid

EUROPE RESEARCH ROUNDUP- Argenx, Hermes, National Grid May 28 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Argenx, Hermes and National Grid, on Tuesday. HIGHLIGHTS * Argenx ARGX.BR : Barclays raises target price to EUR 375 from EUR 360 * Endomines Finland Oyj PAMPALO.HE : Evli Research raises to hold from sell * Hermes HRMS.PA : Bernstein raises to outperform from market perform * National Grid Plc NG.L : RBC cuts target price t
A
A
B
B
B
E
G
H
I
I
J
L
M
R
R
S
S
S
S
S
U
A
N
S

Symrise falls as Q1 sales lag behind peer

BUZZ-Symrise falls as Q1 sales lag behind peer ** Shares in Symrise SY1G.DE are down 4.5% after the German flavour and fragrance maker beat Q1 sales estimates but the results lagged behind those of Swiss peer Givaudan ** Symrise said its Q1 sales rose 5% in the reporting currency to 1.29 billion euros ($1.38 billion), above analysts' average foreca
G
S

Symrise beats Q1 sales expectations but lags peer

UPDATE 2-Symrise beats Q1 sales expectations but lags peer Includes shares, peer comparison in paragraphs 1-6 By Bartosz Dabrowski April 25 (Reuters) - Symrise SY1G.DE beat first-quarter sales estimates on Thursday on higher demand b ut shares in the German flavour and fragrance maker fell as the result lagged behind Swiss peer Givaudan GIVN.S . The stock was down 3.6% as of 0750 GMT after S ymrise's January-March revenue rose 5% in the reporting currency to 1.29 billion euros ($1.38 billion), a
G
K
L
S

ASML Holding, Flutter Entertainment, Topdanmark

EUROPE RESEARCH ROUNDUP-ASML Holding, Flutter Entertainment, Topdanmark April 18 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including ASML Holding, Flutter Entertainment and Topdanmark, on Thursday. HIGHLIGHTS * Adidas AG ADSGn.DE : Barclays raises target price to EUR 231 from EUR 227 * ASML Holding NV ASML.AS : TD Cowen raises target price to EUR 1,050 from EUR 1,000 * Flutter Entertainment FLTRF.L : HSBC cuts to hold from buy * Henkel
A
A
B
C
D
D
E
E
G
G
H
H
R
S
A
A
A
A
A
B
D
F
N
R
W

Aston Martin, Puma, Societe Generale

EUROPE RESEARCH ROUNDUP-Aston Martin, Puma, Societe Generale April 15 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Aston Martin, Puma and Societe Generale, on Monday. HIGHLIGHTS * Aston Martin AML.L : JP Morgan cuts target price to 260p from 323p * Danske Bank DANSKE.CO : HSBC raises target price to DKK 238 from DKK 229 * Novo Nordisk NOVOb.CO : Morgan Stanley raises target price to DKK 990 from DKK 930 * Puma SE PUMG.DE : JP Mo
A
A
A
B
B
B
C
C
D
D
E
E
E
E
E
E
G
H
I
L
P
S
Z
A
A
B
E

ABN Amro Bank, Evotec, Glencore

EUROPE RESEARCH ROUNDUP-ABN Amro Bank, Evotec, Glencore April 12 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including ABN Amro Bank, Evotec and Glencore, on Friday. HIGHLIGHTS * ABN Amro Bank NV ABNd.AS : Goldman Sachs cuts to neutral * Evotec EVTG.DE : Deutsche Bank raises to buy from hold * Glencore GLEN.L : Jefferies raises target price to 550p from 520p * JTC Plc JTC.L : HSBC cuts target price to 1,050p from 1,080p * VAT Group AG VA
A
A
A
A
A
B
B
D
E
E
E
G
G
A
A
A
B
D
G

Swiss stocks - Factors to watch on April 12

Swiss stocks - Factors to watch on April 12 ZURICH/BERLIN, April 12 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Friday: UBS UBSG.S UBS might need to retain $10 billion to $15 billion in excess capital after Switzerland's government this week laid out plans for tougher capital requirements for the enlarged lender, Autonomous Research estimated on Thursday.
G
S
S
Z

Firmenich shares get boost from Givaudan Q1 sales beat

BUZZ-DSM-Firmenich shares get boost from Givaudan Q1 sales beat ** Dutch flavouring producer DSM-Firmenich DSFIR.AS rises about 2.5%, analysts point to Swiss peer Givaudan GIVN.S Q1 sales beating expectations ** "Investors seem to be making positive inferences about the performance of the legacy Firmenich business, especially in fragrances," Berenb
G
N

Futures point to flat start ahead of ECB

LIVE MARKETS-Futures point to flat start ahead of ECB Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com FUTURES POINT TO FLAT START AHEAD OF ECB European stocks look set for a lacklustre opoen, as traders hold their breath for the European Central Bank's policy meeting due later, with expectations that rates will be held at a record high .
A
G
L
E
F
U
G

Givaudan rises as Q1 sales beat implies underlying improvement

BUZZ-Givaudan rises as Q1 sales beat implies underlying improvement ** Shares in Swiss fragrance and flavour maker Givaudan GIVN.S rise 2.85% in Julius Baer premarket trade after it beat Q1 sales expectations ** Q1 sales rise by 2.8% to 1.82 billion Swiss francs ($1.99 billion), vs consensus of 1.78 billion francs ** "Though the company likely bene
G
S
J
S
G

Swiss stocks - Factors to watch on April 11

Swiss stocks - Factors to watch on April 11 ZURICH/BERLIN, April 11 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Thursday: BANKING REGULATION Swiss financial regulator FINMA welcomed the government's report into new financial regulations to oversee UBS UBSG.S and other lenders following the 2023 implosion of Credit Suisse.
A
G
H
U
J

Givaudan Q1 sales beat expectations as volumes increase

UPDATE 1-Givaudan Q1 sales beat expectations as volumes increase Adds context, quote and division results from paragraph 3 April 11 (Reuters) - Swiss fragrance and flavour maker Givaudan GIVN.S reported first-quarter sales above market expectations on Thursday, driven by improving volume demand and good business momentum. Its revenue in the January-March period rose 2.8% to 1.82 billion Swiss francs ($1.99 billion), compared with analysts' average forecast of 1.78 billion francs in a poll compil
G

Givaudan first-quarter sales beat expectations

Givaudan first-quarter sales beat expectations April 11 (Reuters) - Swiss fragrance and flavour maker Givaudan GIVN.S reported first-quarter sales above market expectations on Thursday, driven by improving volume demand and good business momentum. Its revenue in the January-March period rose 2.8% to 1.82 billion Swiss francs ($1.99 billion), compared with analysts' average forecast of 1.78 billion francs in a poll compiled by the company.
G

Givaudan Q1 Sales At CHF 1.82 Bln

BRIEF-Givaudan Q1 Sales At CHF 1.82 Bln April 11 (Reuters) - GIVAUDAN SA GIVN.S : IN FIRST THREE MONTHS OF 2024 GIVAUDAN RECORDED SALES OF CHF 1,822 MILLION, AN INCREASE OF 12.6% ON A LIKE-FOR-LIKE (LFL) BASIS1 AND AN INCREASE OF 2.8% IN SWISS FRANCS STRONG GROWTH WAS ACHIEVED ACROSS PRODUCT SEGMENTS AND GEOGRAPHIES, WITH HIGH GROWTH MARKETS GROWIN
G

Swiss stocks - Factors to watch on April 10

Swiss stocks - Factors to watch on April 10 ZURICH/BERLIN, April 10 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Wednesday: SWISS NATIONAL BANK SNBN.S The Swiss National Bank's foreign exchange interventions are a vital tool in the central bank's campaign against both inflationary and deflationary pressures, Vice Chairman Martin Schlegel said on Tuesday.
B
D
D
G
N
R
S
Z
I



Όροι

Δημοφιλή περιουσιακά στοιχεία

Δήλωση αποποίησης ευθύνης: Οι οντότητες του ομίλου XM Group παρέχουν υπηρεσίες σε βάση εκτέλεσης μόνο και η πρόσβαση στην ηλεκτρονική πλατφόρμα συναλλαγών μας που επιτρέπει στον ενδιαφερόμενο να δει ή/και να χρησιμοποιήσει το περιεχόμενο που είναι διαθέσιμο στην ιστοσελίδα μας ή μέσω αυτής, δε διαφοροποιεί ούτε επεκτείνει αυτές τις υπηρεσίες πέραν αυτού ούτε προορίζεται για κάτι τέτοιο. Η εν λόγω πρόσβαση και χρήση υπόκεινται σε: (i) Όρους και προϋποθέσεις, (ii) Προειδοποιήσεις κινδύνου και (iii) Πλήρη δήλωση αποποίησης ευθύνης. Ως εκ τούτου, το περιεχόμενο αυτό παρέχεται μόνο ως γενική πληροφόρηση. Λάβετε ιδιαιτέρως υπόψη σας ότι τα περιεχόμενα της ηλεκτρονικής πλατφόρμας συναλλαγών μας δεν αποτελούν παρότρυνση, ούτε προσφορά για να προβείτε σε οποιεσδήποτε συναλλαγές στις χρηματοπιστωτικές αγορές. Η πραγματοποίηση συναλλαγών στις χρηματοπιστωτικές αγορές ενέχει σημαντικό κίνδυνο για το κεφάλαιό σας.

Όλο το υλικό που δημοσιεύεται στην ηλεκτρονική πλατφόρμα συναλλαγών μας προορίζεται για εκπαιδευτικούς/ενημερωτικούς σκοπούς μόνο και δεν περιέχει, ούτε θα πρέπει να θεωρηθεί ότι περιέχει συμβουλές και συστάσεις χρηματοοικονομικές ή σε σχέση με φόρο επενδύσεων και την πραγματοποίηση συναλλαγών, ούτε αρχείο των τιμών διαπραγμάτευσής μας ούτε και προσφορά ή παρότρυνση για συναλλαγή οποιωνδήποτε χρηματοπιστωτικών μέσων ή ανεπιθύμητες προς εσάς προωθητικές ενέργειες.

Οποιοδήποτε περιεχόμενο τρίτων, καθώς και περιεχόμενο που εκπονείται από την ΧΜ, όπως απόψεις, ειδήσεις, έρευνα, αναλύσεις, τιμές, άλλες πληροφορίες ή σύνδεσμοι προς ιστότοπους τρίτων το οποίο περιέχεται σε αυτήν την ιστοσελίδα παρέχεται «ως έχει», ως γενικός σχολιασμός της αγοράς και δεν αποτελεί επενδυτική συμβουλή. Στον βαθμό που οποιοδήποτε περιεχόμενο ερμηνεύεται ως επενδυτική έρευνα, πρέπει να λάβετε υπόψη και να αποδεχτείτε ότι το περιεχόμενο δεν προοριζόταν και δεν έχει προετοιμαστεί σύμφωνα με τις νομικές απαιτήσεις που αποσκοπούν στην προώθηση της ανεξαρτησίας της επενδυτικής έρευνας και ως εκ τούτου, θα πρέπει να θεωρηθεί ως επικοινωνία μάρκετινγκ σύμφωνα με τους σχετικούς νόμους και κανονισμούς. Παρακαλούμε εξασφαλίστε ότι έχετε διαβάσει και κατανοήσει τη Γνωστοποίησή μας περί Μη ανεξάρτητης επενδυτικής έρευνας και την Προειδοποίηση ρίσκου όσον αφορά τις παραπάνω πληροφορίες, τις οποίες μπορείτε να βρείτε εδώ.

Προειδοποίηση ρίσκου: Τα κεφάλαιά σας κινδυνεύουν. Τα προϊόντα με μόχλευση ενδέχεται να μην είναι κατάλληλα για όλους. Παρακαλούμε λάβετε υπόψη σας τη Γνωστοποίηση ρίσκου.